March 26, 2012 article Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation Transplant International DOI: 10.1111/j.1432-2277.2012.01465.x OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 121 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial 2025 Clinical Infectious Diseases article Medicine Renal Transplantation Outcomes and Treatments Open access 5 citations Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients 2021 BMC Nephrology article Medicine Renal Transplantation Outcomes and Treatments Open access 16 citations 2 results References 0